Lifecore Biomedical, Inc. De (LFCR) Receivables - Net (2011 - 2025)

Lifecore Biomedical's Receivables - Net history runs 15 years deep, the most recent figure standing at $15.2 million for Q2 2025.

• In Q2 2025, Receivables - Net fell 6.9% year-over-year to $15.2 million; the TTM figure through May 2025 stood at $15.2 million (down 6.9% YoY), while the FY2025 annual figure was $15.2 million, down 51.37% from the prior year.
• Receivables - Net was $15.2 million for Q2 2025 at Lifecore Biomedical, down from $16.1 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $39.7 million in Q1 2022 to a low of $10.8 million in Q4 2023.
• Historically, Receivables - Net has averaged $25.2 million across 5 years, with a median of $27.5 million in 2021.
• Biggest YoY gain for Receivables - Net was 181.34% in 2024; the steepest drop was 61.2% in 2024.
• A 5-year view of Receivables - Net shows it stood at $27.5 million in 2021, then decreased by 0.13% to $27.5 million in 2022, then tumbled by 60.77% to $10.8 million in 2023, then surged by 181.34% to $30.3 million in 2024, then sank by 50.0% to $15.2 million in 2025.
• The last three Receivables - Net figures came in at $15.2 million (Q2 2025), $16.1 million (Q1 2025), and $30.3 million (Q4 2024), per Business Quant data.